Dec 8, 2015 7:00am EST Tonix Pharmaceuticals Completes Enrollment in Phase 2 Clinical Study of TNX-201 in Episodic Tension-Type Headache
Dec 7, 2015 7:00am EST Tonix Pharmaceuticals and U.S. Department of Defense Military Developer in Partnership to Expand Efforts to Examine TNX-102 SL for Post-Traumatic Stress Disorder
Dec 1, 2015 7:00am EST Tonix Pharmaceuticals to Participate in Fireside Chat at the Oppenheimer 26th Annual Healthcare Conference
Nov 10, 2015 8:30am EST Tonix Pharmaceuticals Presents Additional Data on Tonmya(TM) Demonstrating Improvements in Sleep, Pain, and Other Outcomes in Fibromyalgia at 2015 ACR/ARHP Annual Meeting
Nov 9, 2015 7:00am EST Tonix Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Programs Update
Oct 1, 2015 7:00am EDT Tonix Pharmaceuticals Announces Acceptance of Three Abstracts to be Presented at the 2015 ACR/ARHP Annual Meeting
Sep 24, 2015 7:00am EDT Tonix Pharmaceuticals to Present at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment
Sep 8, 2015 7:05am EDT Tonix Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference
Aug 18, 2015 1:00pm EDT Tonix Pharmaceuticals Presents on the Development of TNX-102 SL for Post-Traumatic Stress Disorder (PTSD) at the 2015 Military Health System Research Symposium
Aug 10, 2015 7:00am EDT Tonix Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Program Update
